Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adenosine vs Verapamil for Post-CABG SVT
NCT04203368Completed
- Sponsor
- Ain Shams University
- Start
- Feb 2020
- Primary completion
- Jul 2020
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Randomised, double-blind trial of adenosine in supraventricular tachycardia (SVT) (2 arms), sponsored by Ain Shams University. Primary endpoint: Efficacy of the study drug (Conversion to Sinus Rhythm). Started Feb 2020; status: completed.
02
Drugs
adenosine
03
Conditions
supraventricular tachycardia (SVT)
Beyond the preview
Go deeper on NCT04203368.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04203368.